Novo Nordisk (NYSE: NVO) got fantastic news last year when regulators approved its weight loss pill. It's the first oral GLP-1 drug in the market, and it unlocks a huge new growth opportunity for the ...
The Senate passed a deal Friday evening to avert a government shutdown but the bill requires House approval, meaning the government is set for a partial government shutdown beginning at midnight which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results